Literature DB >> 26187358

The importance of the multidisciplinary approach to deal with the new epidemiological scenario of Chagas disease (global health).

Maria-Jesus Pinazo1, Joaquim Gascon2.   

Abstract

There are currently two major factors that have modified the epidemiology of Chagas disease in the last decades: climate change and migration flows. In this new scenario, there are new challenges to control and prevent Trypanosoma cruzi infection in endemic countries, such as the control of a wider distribution of triatomine vectors or the reinforcement of vertical transmission programs. In non-endemic areas, few countries are aware of the emergence of this new disease and have established changes in their health systems. To address this new public health challenge, the priorities should be control programs to avoid new cases of T. cruzi infection acquired through vertical transmission, blood transfusion or organ transplant. In both, endemic and non-endemic areas, the international community and all the actors involved in Chagas disease must join efforts mainly in two directions: better management of the infection in affected individuals and more research to cover the knowledge gap mainly in physiopathology, diagnosis and treatment.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Benznidazole; Chagas disease; Migration; Oral transmission; Triatoma infestans; Trypanosoma cruzi

Mesh:

Year:  2015        PMID: 26187358     DOI: 10.1016/j.actatropica.2015.06.013

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  16 in total

1.  Serological Diagnosis of Chronic Chagas Disease: Is It Time for a Change?

Authors:  Alba Abras; Montserrat Gállego; Teresa Llovet; Silvia Tebar; Mercedes Herrero; Pere Berenguer; Cristina Ballart; Carmen Martí; Carmen Muñoz
Journal:  J Clin Microbiol       Date:  2016-04-06       Impact factor: 5.948

Review 2.  Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.

Authors:  Cristina Fonseca-Berzal; Vicente J Arán; José A Escario; Alicia Gómez-Barrio
Journal:  Parasitol Res       Date:  2018-09-19       Impact factor: 2.289

3.  Towards a New Strategy for Diagnosis of Congenital Trypanosoma cruzi Infection.

Authors:  Alba Abras; Carmen Muñoz; Cristina Ballart; Pere Berenguer; Teresa Llovet; Mercedes Herrero; Silvia Tebar; María-Jesús Pinazo; Elizabeth Posada; Carmen Martí; Victoria Fumadó; Jordi Bosch; Oriol Coll; Teresa Juncosa; Gemma Ginovart; Josep Armengol; Joaquim Gascón; Montserrat Portús; Montserrat Gállego
Journal:  J Clin Microbiol       Date:  2017-02-15       Impact factor: 5.948

4.  Population movements, borders, and Chagas disease.

Authors:  Andrea Avaria; Laia Ventura-Garcia; Mariana Sanmartino; Carlos Van der Laat
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-07-08       Impact factor: 2.747

Review 5.  Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection.

Authors:  Carmen Muñoz; Montserrat Gállego; Alba Abras; Cristina Ballart; Anna Fernández-Arévalo; María-Jesús Pinazo; Joaquim Gascón
Journal:  Clin Microbiol Rev       Date:  2022-03-03       Impact factor: 50.129

Review 6.  A global systematic review of Chagas disease prevalence among migrants.

Authors:  Erin E Conners; Joseph M Vinetz; John R Weeks; Kimberly C Brouwer
Journal:  Acta Trop       Date:  2016-01-08       Impact factor: 3.112

7.  Acrylonitrile Derivatives against Trypanosoma cruzi: In Vitro Activity and Programmed Cell Death Study.

Authors:  Carlos J Bethencourt-Estrella; Samuel Delgado-Hernández; Atteneri López-Arencibia; Desirée San Nicolás-Hernández; Ines Sifaoui; David Tejedor; Fernando García-Tellado; Jacob Lorenzo-Morales; José E Piñero
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-09

8.  Genetic Susceptibility to Cardiac and Digestive Clinical Forms of Chronic Chagas Disease: Involvement of the CCR5 59029 A/G Polymorphism.

Authors:  Amanda Priscila de Oliveira; Cássia Rubia Bernardo; Ana Vitória da Silveira Camargo; Luiz Sérgio Ronchi; Aldenis Albaneze Borim; Cinara Cássia Brandão de Mattos; Eumildo de Campos Júnior; Lílian Castiglioni; João Gomes Netinho; Carlos Eugênio Cavasini; Reinaldo Bulgarelli Bestetti; Luiz Carlos de Mattos
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

Review 9.  Salvia Species as Sources of Natural Products with Antiprotozoal Activity.

Authors:  Núria Llurba-Montesino; Thomas J Schmidt
Journal:  Int J Mol Sci       Date:  2018-01-16       Impact factor: 5.923

10.  2b-RAD genotyping for population genomic studies of Chagas disease vectors: Rhodnius ecuadoriensis in Ecuador.

Authors:  Luis E Hernandez-Castro; Marta Paterno; Anita G Villacís; Björn Andersson; Jaime A Costales; Michele De Noia; Sofía Ocaña-Mayorga; Cesar A Yumiseva; Mario J Grijalva; Martin S Llewellyn
Journal:  PLoS Negl Trop Dis       Date:  2017-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.